| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/14/2005 | WO2005032530A1 Pharmaceutical composition for external application |
| 04/14/2005 | WO2005032529A1 Mycocide composition |
| 04/14/2005 | WO2005032528A2 Use of antifungal agents for treating of otitis externa |
| 04/14/2005 | WO2005032527A2 Benzo (4, 5) thieno (2, 3-d) pyrimidin-4-ones and their use in therapy |
| 04/14/2005 | WO2005032526A1 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 04/14/2005 | WO2005032522A1 Topical aerosol foams |
| 04/14/2005 | WO2005032521A2 Non-flammable topical anesthetic liquid aerosols |
| 04/14/2005 | WO2005032520A1 Buccal, polar and non-polar spray containing ondansetron |
| 04/14/2005 | WO2005032519A1 Buccal, polar and non-polar spray containing zolpidem |
| 04/14/2005 | WO2005032518A1 Buccal, polar and non-polar spray containing sumatriptan |
| 04/14/2005 | WO2005032517A1 Buccal, polar and non-polar spray containing diazepam |
| 04/14/2005 | WO2005032515A1 New use, pharmaceutical preparations as well as a process for their production |
| 04/14/2005 | WO2005032514A1 Transdermal pharmaceutical composition |
| 04/14/2005 | WO2005032513A2 Pantoprazole multiparticulate formulations |
| 04/14/2005 | WO2005032510A1 Triamcinolone acetonide and anecortave acetate formulations for injection |
| 04/14/2005 | WO2005032496A2 Hydrolases, nucleic acids encoding them and mehods for making and using them |
| 04/14/2005 | WO2005032493A2 Amide compounds as ion channel ligands and uses thereof |
| 04/14/2005 | WO2005032489A2 Coated metal pyrithione particles for treatment of microorganisms |
| 04/14/2005 | WO2005032488A2 2,4-dioxo-3-quinazolinylaryl sulfonylureas |
| 04/14/2005 | WO2005032485A2 Compounds and methods for the treatment of attention-deficit hyperactivity disorder |
| 04/14/2005 | WO2005032484A2 Alkoxy substituted imidazoquinolines |
| 04/14/2005 | WO2005032483A2 Polysaccharides for pulmonary delivery of active agents |
| 04/14/2005 | WO2005032481A2 Quinazoline derivatives as medicaments |
| 04/14/2005 | WO2005032479A2 Compositions and methods for selective inhibition of nicotine acetylcholine receptors |
| 04/14/2005 | WO2005032478A2 Treatment for diabetic microvascular and macrovascular complications |
| 04/14/2005 | WO2005032477A2 Gamma-tocopherol treatment for cystic fibrosis |
| 04/14/2005 | WO2005032472A2 Pyrrolidine and piperidine derivatives as factor xa inhibitors |
| 04/14/2005 | WO2005032471A2 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/14/2005 | WO2005032470A2 Compositions and methods for treating burns |
| 04/14/2005 | WO2005032468A2 Monocyclic and bicyclic lactams as factor xa inhibitors |
| 04/14/2005 | WO2005032466A2 Calcium phosphate-based materials containig zinc, magnesium, fluoride and carbonate |
| 04/14/2005 | WO2005032465A2 3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists |
| 04/14/2005 | WO2005032464A2 Phenyl pyrrolidine ether tachykinin receptor antagonists |
| 04/14/2005 | WO2005032462A2 Glucocerebroside treatment of disease |
| 04/14/2005 | WO2005032459A2 Erythrosin-based antimicrobial photodynamic therapy compound and its use |
| 04/14/2005 | WO2005032343A2 Hedgehog signaling in prostate regeneration neoplasia and metastasis |
| 04/14/2005 | WO2005032278A1 SOLUBILIZED CoQ-10 |
| 04/14/2005 | WO2005032234A2 Agent for reducing ill effects of acute alcohol intoxication |
| 04/14/2005 | WO2005021038A3 Agent for treating metabolic syndrome |
| 04/14/2005 | WO2005021005A3 Process for the preparation of 1,4-benzodiazepine derivatives |
| 04/14/2005 | WO2005020684A3 Control of protozoa and protozoan cysts that harbor legionella |
| 04/14/2005 | WO2005016883A3 Acrylamide derivatives as vla-1 integrin antagonists and uses thereof |
| 04/14/2005 | WO2005016859A3 Proteasome inhibitors and methods of using the same |
| 04/14/2005 | WO2005016327A3 Treatment of sleep disorders with cholinesterase inhibitors |
| 04/14/2005 | WO2005016286A8 Pyrazine modulators of cannabinoid receptors |
| 04/14/2005 | WO2005016275A3 Formulations containing an immune response modifier |
| 04/14/2005 | WO2005014783A3 Reducing axon degeneration with proteasome inhibitors |
| 04/14/2005 | WO2005013892A9 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 04/14/2005 | WO2005012485A3 Methods for treating diabetes and related disorders using pde10a inhibitors |
| 04/14/2005 | WO2005011741A3 Delivery of a drug via subconjuctival or periocular delivery of a prodrug in a polymeric microparticle |
| 04/14/2005 | WO2005011734A3 Composition of a vegf antagonist and an anti-proliferative agent and its use for the treatment of cancer |
| 04/14/2005 | WO2005011654A3 Pyridyl derivatives and their use as therapeutic agents |
| 04/14/2005 | WO2005011653A3 Pyridazine derivatives and their use as therapeutic agents |
| 04/14/2005 | WO2005011645A3 Selected betaines and their uses |
| 04/14/2005 | WO2005011639A3 Effervescent pharmaceutical compositions containing vitamin d, calcium and phospate and their therapeutic use |
| 04/14/2005 | WO2005011588A3 Polymorphs of butylated hydroxy anisole |
| 04/14/2005 | WO2005007665A8 Lincomycin derivatives possessing antibacterial activity |
| 04/14/2005 | WO2005007111A3 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 04/14/2005 | WO2005007099A3 Pkb inhibitors as anti-tumor agents |
| 04/14/2005 | WO2005007081A3 Compounds and methods for delivery of prostacyclin analogs |
| 04/14/2005 | WO2005004860A3 Novel solid pharmaceutical composition comprising amisulpride |
| 04/14/2005 | WO2005004806A3 Combination therapy for treating chronic inflammatory diseases |
| 04/14/2005 | WO2005002602A3 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 04/14/2005 | WO2005002559A3 Methods of inhibiting vascular permeability and apoptosis |
| 04/14/2005 | WO2005001040A3 Non-lethal conditioning methods for conditioning a recipient for bone marrow transplantation |
| 04/14/2005 | WO2005000325A3 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
| 04/14/2005 | WO2005000318A3 Method of inducing apoptosis and inhibiting cardiolipin synthesis |
| 04/14/2005 | WO2005000281A3 Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 04/14/2005 | WO2005000247A3 4-carboxamido quinoline derivatives for use as nk-2 and nk-3 |
| 04/14/2005 | WO2005000196A3 Inhibition of egr-1 expression by rpar-ϝ agonista and related compositions and methods |
| 04/14/2005 | WO2004112786A3 Gaboxadol for treating depression and other affective disorders |
| 04/14/2005 | WO2004112706A3 Vaccines, immunotherapeutics and methods for using the same |
| 04/14/2005 | WO2004112699A3 Mitotic kinesin inhibitors |
| 04/14/2005 | WO2004110408A3 Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol |
| 04/14/2005 | WO2004110374A3 3,4-disubstituted benzamidines and benzylamines, and analogues thereof, useful as serine protease inhibitors |
| 04/14/2005 | WO2004110348A3 Saururus cernuus compounds that inhibit cellular responses to hypoxia |
| 04/14/2005 | WO2004108746A3 11-12 bicyclic erythromycin derivatives |
| 04/14/2005 | WO2004108061A3 Stable injectable pharmaceutical composition of thiopental; method for stabilizing aqueous solutions of thiopental and, use of thiopental for producing a medicament |
| 04/14/2005 | WO2004105700A3 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 04/14/2005 | WO2004103961A3 Sulfated bis-cyclic agents |
| 04/14/2005 | WO2004103374A3 Imatinib combinations for head and neck cancers |
| 04/14/2005 | WO2004100891A3 Cytotoxic indeno and isoindoloisoquinolones |
| 04/14/2005 | WO2004099154A3 Pyrazole-amides and sulfonamides as sodium channel modulators |
| 04/14/2005 | WO2004098525A3 Uses of ion channel modulating compounds |
| 04/14/2005 | WO2004096216A3 Use of a topical medicament comprising riluzole |
| 04/14/2005 | WO2004096197A8 5-aza-7-deazapurine nucleosides for treating flaviviridae |
| 04/14/2005 | WO2004096146A3 Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage |
| 04/14/2005 | WO2004093917A3 Intranasal administration of triptans |
| 04/14/2005 | WO2004093650A3 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid |
| 04/14/2005 | WO2004092215A3 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 04/14/2005 | WO2004092124A3 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 04/14/2005 | WO2004092121A3 Methods for preparing 2,3,5,6-substituted 3h-pyrimidin-4-ones |
| 04/14/2005 | WO2004092120A3 Pyrimidinone compounds as calcilytics |
| 04/14/2005 | WO2004091597A3 Method of treating irritable bowel syndrome (ibs) |
| 04/14/2005 | WO2004091542A3 Nitrogen containing integrin targeting compounds |
| 04/14/2005 | WO2004084911A3 Use of roxithromycin or its derivatives for the modulation of immune responses |
| 04/14/2005 | WO2004075848A3 Antitumor inhibitors and use thereof |
| 04/14/2005 | WO2004075775A3 Treatment of excessive osteolyisis with indolinone compounds |
| 04/14/2005 | WO2004074444A3 Ferric organic compounds, uses thereof and methods of making same |
| 04/14/2005 | WO2004073711A3 Methods involving pde4, compositions, and the screening thereof, for the treatment of degenerative ocular pathologies |